Stefanie Sun

Stefanie Sun has held various positions in the pharmaceutical industry since 2005. Stefanie began their career as a Chemist II at Impax Laboratories in 2005. In 2011, they moved to Amgen as a QC Publisher I. From 2012 to 2015, they worked at Threshold Pharmaceuticals as a Clinical Research Associate and Clinical Research Assistant. From 2015 to 2017, they worked at Gilead Sciences as a Sr. CTM Associate and CTM Associate. From 2017 to 2021, they were a Clinical Program Manager, Sr Clinical Trial Manager, and Clinical Trial Manager at Five Prime Therapeutics, Inc. Stefanie is currently an Associate Director at Enliven Therapeutics.

Stefanie Sun attended the University of California, Davis from 2001 to 2003, where they earned a Bachelor of Science degree in Environmental Resource Science.